Jelle Folkerts

Jelle Folkerts

Auto-generated profile, based on publicly available information

Jelle Folkerts

Department of Pathology Stanford University School of Medicine California USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2020 in Allergy
Verified
Journal Article
Open access
PDF file
JFJelle Folkerts
Jelle Folkerts
FRFrank Redegeld
Frank Redegeld
GFGert Folkerts
Gert Folkerts
BBBart Blokhuis
Bart Blokhuis
MBMariska P. M. van Den Berg
Mariska P. M. van Den Berg
MMMarcus Maurer
Marcus Maurer
Background: Short‐chain fatty acids (SCFAs) are fermented dietary components that regulate immune responses, promote colonic health, and suppress mast cell–mediated diseases. However, the effects of SCFAs on human mast cell function, including the underlying mechanisms, remain unclear. Here, we investigated the effects of the SCFAs (acetate, propionate, and butyrate) on mast cell–mediated pathology and human mast cell activation, including the molecular mechanisms involved.Method: Precision‐cut lung slices (PCLS) of allergen‐exposed guinea pigs were used to assess the effects of butyrate on allergic airway contraction. Human and mouse mast cells were co‐cultured with SCFAs and assessed for degranulation after IgE‐ or non–IgE‐mediated stimulation. The underlying mechanisms involved were investigated using knockout mice, small molecule inhibitors/agonists, and genomics assays.Results: Butyrate treatment inhibited allergen‐induced histamine release and airway contraction in guinea pig PCLS. Propionate and butyrate, but not acetate, inhibited IgE‐ and non–IgE‐mediated human or mouse mast cell degranulation in a concentration‐dependent manner. Notably, these effects were independent of the stimulation of SCFA receptors GPR41, GPR43, or PPAR, but instead were associated with inhibition of histone deacetylases. Transcriptome analyses revealed butyrate‐induced downregulation of the tyrosine kinases BTK, SYK, and LAT, critical transducers of FcεRI‐mediated signals that are essential for mast cell activation. Epigenome analyses indicated that butyrate redistributed global histone acetylation in human mast cells, including significantly decreased acetylation at the BTK, SYK, and LAT promoter regions.Conclusion: Known health benefits of SCFAs in allergic disease can, at least in part, be explained by epigenetic suppression of human mast cell activation.

30 October 2019 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
YCYang Cai
Yang Cai
JFJelle Folkerts
Jelle Folkerts
GFGert Folkerts
Gert Folkerts
MMMarcus Maurer
Marcus Maurer
SBSaskia Braber
Saskia Braber
Dietary fibre, such as indigestible oligosaccharides and polysaccharides, occurs in many foods and has gained considerable importance related to its beneficial effects on host health and specific diseases. Dietary fibre is neither digested nor absorbed in the small intestine and modulates the composition of the gut microbiota. New evidence indicates that dietary fibre also interacts directly with the epithelium and immune cells throughout the gastrointestinal tract by microbiota‐independent effects. This review focuses on how dietary fibre improves human health and the reported health benefits that are connected to molecular pathways, in (a) a microbiota‐independent manner, via interaction with specific surface receptors on epithelial and immune cells regulating intestinal barrier and immune function, and (b) a microbiota‐dependent manner via maintaining intestinal homeostasis by promoting beneficial microbes, including Bifidobacteria and Lactobacilli, limiting the growth, adhesion, and cytotoxicity of pathogenic microbes, as well as stimulating fibre‐derived microbial short‐chain fatty acid production.Linked Articles: This article is part of a themed section on The Pharmacology of Nutraceuticals. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.6/issuetoc

29 May 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JFJelle Folkerts
Jelle Folkerts
RSRalph Stadhouders
Ralph Stadhouders
FRFrank A. Redegeld
Frank A. Redegeld
STSee-Ying Tam
See-Ying Tam
RHRudi W. Hendriks
Rudi W. Hendriks
MMMarcus Maurer
Marcus Maurer
Many mast cell-associated diseases, including allergies and asthma, have seen a strong increase in prevalence during the past decades, especially in Western(ized) countries. It has been suggested that a Western diet may contribute to the prevalence and manifestation of allergies and asthma through reduced intake of dietary fiber and the subsequent production of their metabolites. Indeed, dietary fiber and its metabolites have been shown to positively influence the development of immune disorders via changes in microbiota composition and the regulation of B- and T-cell activation. However, the effects of these dietary components on the activation of mast cells, key effector cells of the inflammatory response in allergies and asthma, remain poorly characterized. Due to their location in the gut and vascularized tissues, mast cells are exposed to high concentrations of dietary fiber and/or its metabolites. Here, we provide a focused overview of current findings regarding the direct effects of dietary fiber and its various metabolites on the regulation of mast cell activity and the pathophysiology of mast cell-associated diseases.

14 February 2020 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
JFJelle Folkerts
Jelle Folkerts
NGNicolas Gaudenzio
Nicolas Gaudenzio
MMMarcus Maurer
Marcus Maurer
Rudi HendriksRudi Hendriks
Rudi Hendriks
RSRalph Stadhouders
Ralph Stadhouders
SGStephen J. Galli
Stephen J. Galli

30 October 2018 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
EMEsmaeil Mortaz
Esmaeil Mortaz
SASaeede Amani
Saeede Amani
SMSharon Mumby
Sharon Mumby
IAIan Adcock
Ian Adcock
MMMehrnaz Movassaghi
Mehrnaz Movassaghi
GFGert Folkerts
Gert Folkerts
The multifunctional role of mast cells (MCs) in the immune system is complex and has not fully been explored. MCs reside in tissues and mucous membranes such as the lung, digestive tract, and skin which are strategically located at interfaces with the external environment. These cells, therefore, will encounter external stimuli and pathogens. MCs modulate both the innate and the adaptive immune response in inflammatory disorders including transplantation. MCs can have pro- and anti-inflammatory functions, thereby regulating the outcome of lung transplantation through secretion of mediators that allow interaction with other cell types, particularly innate lymphoid cells (ILC2). ILC2 cells are a unique population of hematopoietic cells that coordinate the innate immune response against a variety of threats including infection, tissue damage, and homeostatic disruption. In addition, MCs can modulate alloreactive T cell responses or assist in T regulatory (Treg) cell activity. This paper outlines the current understanding of the role of MCs in lung transplantation, with a specific focus on their interaction with ILC2 cells within the engrafted organ.

18 April 2026 in Allergy
Verified
Journal Article
Closed access
PDF file
JFJelle Folkerts
Jelle Folkerts
PTPaula van Tienen
Paula van Tienen
MBMarjolein J. W. de Bruijn
Marjolein J. W. de Bruijn
WIWilfred van IJcken
Wilfred van IJcken
Rudi HendriksRudi Hendriks
Rudi Hendriks
SGStephen J. Galli
Stephen J. Galli